Generic competition · all medicines · read 12 November 2026
Is there a generic of Lidocaine, and who makes it?
Lidocaine appears in 7 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 19 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 16.3 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Lidocaine appears in 7 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 19 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came 16.3 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Ointment, Topical
Four or more generic makers listed
Every brand product here is listed as discontinued. 13 generic makers with 13 generic products listed as marketed; the first generic approval is dated 23 May 2011.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Fougera Pharmaceuticals Inc | not dated | 1 |
| Sun Pharma Canada Inc | not dated | 1 |
| Septodont Inc | 23 May 2011 | 1 |
| Amneal Pharmaceuticals | 7 August 2015 | 1 |
| Encube Ethicals Private Ltd | 1 February 2016 | 1 |
| Glenmark Pharmaceuticals Ltd | 9 September 2016 | 1 |
| Alkem Laboratories Ltd | 10 March 2017 | 1 |
| Alembic Pharmaceuticals Ltd | 23 November 2018 | 1 |
| Strides Pharma Global Pte Ltd | 11 December 2018 | 1 |
| Macleods Pharmaceuticals Ltd | 16 March 2020 | 1 |
| Chartwell Rx Sciences Llc | 5 January 2021 | 1 |
| Quagen Pharmaceuticals Llc | 20 April 2021 | 1 |
1 more makers are listed in the data.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Patch, Topical
Four or more generic makers listed
Brand listed as marketed: Lidoderm and Ztlido. 8 generic makers with 8 generic products listed as marketed; the first generic approval is dated 23 August 2012.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Actavis Laboratories Ut Inc | 23 August 2012 | 1 |
| Pharmobedient Consulting Llc | 7 August 2015 | 1 |
| Ibsa Institut Biochimique Sa | 30 April 2020 | 1 |
| Amneal Pharmaceuticals Llc | 24 August 2020 | 1 |
| Nal Pharmaceutical Group Ltd | 29 April 2021 | 1 |
| Difgen Pharmaceuticals Llc | 25 March 2025 | 1 |
| Alkem Laboratories Ltd | 6 October 2025 | 1 |
| Invagen Pharmaceuticals Inc | 9 February 2026 | 1 |
Patents and exclusivities still listed
- 10 May 2031Patent 9925264 drug product
- 10 May 2031Patent 11786455 drug product
- 10 May 2031Patent 11793766
- 10 May 2031Patent 9283174 drug product
- 10 May 2031Patent 10765749 drug product
- 10 May 2031Patent 9931403 drug product
- 10 May 2031Patent 11278623 drug product
- 10 May 2031Patent 10765640 drug product
Aerosol, Oral
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Film, Extended Release, Buccal
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Topical
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Suppository, Rectal
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
System, Topical
Brand listed, no generic listed as marketed
Brand listed as marketed: Bondlido. No generic is listed as marketed.
Patents and exclusivities still listed
- 24 September 2028Exclusivity NP Bondlido
- 10 November 2028Patent 8722065 drug product
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.